Vimseltinib

Romvimza 30 MG Capsulas Duras

30 mg cápsula duraSpainAuthorisedAuthorised 26 Nov 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RomvimzaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vimseltinib

Romvimza 30 MG Capsulas Duras

30 mg cápsula duraSpainAuthorisedAuthorised 26 Nov 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

RomvimzaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Netherlands · Capsule, hard · Deciphera Pharmaceuticals (Netherlands) B.V.

RomvimzaUnited States · 14MG, 20MG, 30MG · capsule · Deciphera Pharms

Packs

Pack	Code	Status
ROMVIMZA 30 MG CAPSULAS DURAS, 8 cápsulas	769287

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vimseltinib
Strength: 30 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 26 Nov 2025
Registration: 1251968003
Marketing authorisation holder: Deciphera Pharmaceuticals (Netherlands) B.V.
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/25/1968